Identification of FXYD6 as the novel biomarker for glioma based on differential expression and DNA methylation.

Cancer Med · 2023 · PMC10757084 · PMID 38093622

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

As a result, although we have observed a slight trend of difference of OS in Grade IV gliomas, there is no statistical significance.

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.